Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. UGB, Inc.
CRL
•UGB, Inc.

UGB, Inc. – FDA CRL

Record Details

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to UGB, Inc. for its Biologics License Application (BLA) 761151 for UCB4940 (CDP4940), submitted under section 351(a) of the Public Health Service Act. The FDA determined that the application cannot be approved in its current form due to product quality concerns and deficiencies observed during a recent inspection of the UCB Pharma SA manufacturing facility. Satisfactory resolution of these manufacturing deficiencies is a prerequisite for approval. Additionally, UGB, Inc. is required to resubmit the proposed proprietary name, Bimzelx, and provide a comprehensive safety update as described in 21 CFR 314.50(d)(5)(vi)(b). This update must include detailed changes in the safety profile, presentation of new and combined clinical safety data, retabulated trial discontinuations, case reports and narrative summaries for deaths and serious adverse events, updated exposure information, a summary of worldwide safety experience, and English translations of foreign labeling. UGB, Inc. has one year to resubmit a complete response addressing all identified deficiencies or take other available actions, with an option to request a meeting to discuss the necessary steps.

Company
UGB, Inc.
Product type
BLA
Office
Office of Immunology and Inflammation
People
  • Leo DiNapoli, PhD, RAC
  • Strother Dixon
  • Julie G. Beitz
View Company Profile

ID · b91ed186-c1e3-4a41-94b2-e4677e36dbd3

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore UGB, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.